EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO)

42 filings reported holding EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share as of Q1 2025.
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3.79M shares of 30M outstanding shares and own 12.62% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (2.04M shares), VANGUARD GROUP INC (594K shares), Cresset Asset Management, LLC (269K shares), GEODE CAPITAL MANAGEMENT, LLC (199K shares), CITADEL ADVISORS LLC (179K shares), STATE STREET CORP (139K shares), RENAISSANCE TECHNOLOGIES LLC (82.1K shares), BlackRock, Inc. (54.7K shares), FNY Investment Advisers, LLC (52.5K shares), and Compagnie Lombard Odier SCmA (25K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.